Description
Added on the 09/11/2020 20:54:49 - Copyright : Wochit
Pfizer’s experimental vaccine looks to be highly effective at preventing COVID-19. The effective rate sits right at 90% and there are no apparent safety problems, reports HuffPost. However, to be clear, this is all based on the company’s own preliminary data. The announcement got attention around the world, sending financial markets up on hopes. In the U.S., it set off an immediate political controversy regarding the Trump administration. Critics argued over how much credit if any Trump deserves for the apparent medical advancement.
Madrid, Nov 9 (EFECOM).- The Spanish stock market soared on Monday by 9.5% after the companies Pfizer and BioNTech said that their Covid-19 vaccine was 90% effective in tests.FOOTAGE OF MADRID STOCK EXCHANGE
New York (USA), Nov 9 (EFE / EPA), (Camera: Alba Vigaray).- US stocks rocketed on Monday after American pharmaceutical giant Pfizer announced that its candidate Covid-19 vaccine was 90% effective.FOOTAGE OF NEW YORK STOCK EXCHANGE
The American Academy of Pediatrics (AAP) is advising children be included in the vaccine process. They are urging for the immediate inclusion of children in ongoing COVID-19 vaccine research. Preliminary data was released from drug manufacturers Moderna and Pfizer Inc. this month. The data has been extremely impressive, suggesting both vaccines may be more than 90% effective. Members of the AAP say it is essential that the FDA stick to “transparent requirements”. This is for measuring the risks and benefits of vaccines for the population, including children.
Alex Edelman / AFP via Getty Images Dr. Anthony Fauci said that it could take up to 90% of the US population to get vaccinated to reach herd immunity against the coronavirus. "We really don't know what the real number is," Fauci said in an interview with The New York Times. "I think the real range is somewhere between 70 to 90 percent. But, I'm not going to say 90 percent." This month, the US Food and Drug Administration authorized both Moderna and Pfizer and BioNTech's coronavirus vaccine for emergency use which have been rolled out across the country.